Literature DB >> 28414199

Structure of the PRC2 complex and application to drug discovery.

Yi Shi1, Xiao-Xi Wang1, You-Wen Zhuang1, Yi Jiang1, Karsten Melcher2, H Eric Xu1,2.   

Abstract

The polycomb repressive complexes 2 (PRC2) complex catalyzes tri-methylation of histone H3 lysine 27 (H3K27), a repressive chromatin marker associated with gene silencing. Overexpression and mutations of PRC2 are found in a wide variety of cancers, making the catalytic activity of PRC2 an important target of cancer therapy. This review highlights recent structural breakthroughs of the human PRC2 complex bound to the H3K27 peptide and a small molecule inhibitor, which provide critically needed insight into PRC2-targeted drug discovery.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28414199      PMCID: PMC5519257          DOI: 10.1038/aps.2017.7

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  114 in total

1.  Subunit contributions to histone methyltransferase activities of fly and worm polycomb group complexes.

Authors:  Carrie S Ketel; Erica F Andersen; Marcus L Vargas; Jinkyo Suh; Susan Strome; Jeffrey A Simon
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

2.  Structural basis of EZH2 recognition by EED.

Authors:  Zhifu Han; Xinmiao Xing; Min Hu; Yin Zhang; Peiyuan Liu; Jijie Chai
Journal:  Structure       Date:  2007-10       Impact factor: 5.006

3.  EZH2: a potential new target in T-cell lymphoma?

Authors:  Lisa Giulino-Roth
Journal:  Leuk Lymphoma       Date:  2015-02-14

4.  The methyltransferase Ezh2 controls cell adhesion and migration through direct methylation of the extranuclear regulatory protein talin.

Authors:  Merry Gunawan; Nandini Venkatesan; Jia Tong Loh; Jong Fu Wong; Heidi Berger; Wen Hao Neo; Liang Yao Jackson Li; Myint Khun La Win; Yin Hoe Yau; Tiannan Guo; Peter Chi Ee See; Sayuri Yamazaki; Keh Chuang Chin; Alexandre R Gingras; Susana Geifman Shochat; Lai Guan Ng; Siu Kwan Sze; Florent Ginhoux; I-hsin Su
Journal:  Nat Immunol       Date:  2015-03-09       Impact factor: 25.606

5.  Isolation of a cDNA encoding a metal response element binding protein using a novel expression cloning procedure: the one hybrid system.

Authors:  C Inouye; P Remondelli; M Karin; S Elledge
Journal:  DNA Cell Biol       Date:  1994-07       Impact factor: 3.311

6.  Polycomb PHF19 binds H3K36me3 and recruits PRC2 and demethylase NO66 to embryonic stem cell genes during differentiation.

Authors:  Gerard L Brien; Guillermo Gambero; David J O'Connell; Emilia Jerman; Siobhán A Turner; Chris M Egan; Eiseart J Dunne; Maike C Jurgens; Kieran Wynne; Lianhua Piao; Amanda J Lohan; Neil Ferguson; Xiaobing Shi; Krishna M Sinha; Brendan J Loftus; Gerard Cagney; Adrian P Bracken
Journal:  Nat Struct Mol Biol       Date:  2012-11-18       Impact factor: 15.369

7.  Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells.

Authors:  Jamy C Peng; Anton Valouev; Tomek Swigut; Junmei Zhang; Yingming Zhao; Arend Sidow; Joanna Wysocka
Journal:  Cell       Date:  2009-12-24       Impact factor: 41.582

Review 8.  Targeting EZH2 in cancer.

Authors:  Kimberly H Kim; Charles W M Roberts
Journal:  Nat Med       Date:  2016-02       Impact factor: 53.440

9.  PRC2 binds active promoters and contacts nascent RNAs in embryonic stem cells.

Authors:  Syuzo Kaneko; Jinsook Son; Steven S Shen; Danny Reinberg; Roberto Bonasio
Journal:  Nat Struct Mol Biol       Date:  2013-10-20       Impact factor: 15.369

10.  Polycomb repressive complex 2 (PRC2) silences genes responsible for neurodegeneration.

Authors:  Melanie von Schimmelmann; Philip A Feinberg; Josefa M Sullivan; Stacy M Ku; Ana Badimon; Mary Kaye Duff; Zichen Wang; Alexander Lachmann; Scott Dewell; Avi Ma'ayan; Ming-Hu Han; Alexander Tarakhovsky; Anne Schaefer
Journal:  Nat Neurosci       Date:  2016-08-15       Impact factor: 24.884

View more
  10 in total

1.  New twists on long noncoding RNAs: from mobile elements to motile cancer cells.

Authors:  Tuan M Nguyen; Sumayya Alchalabi; Adewunmi Oluwatoyosi; Ali S Ropri; Jason I Herschkowitz; Jeffrey M Rosen
Journal:  RNA Biol       Date:  2020-06-10       Impact factor: 4.652

2.  C10ORF12 modulates PRC2 histone methyltransferase activity and H3K27me3 levels.

Authors:  Yi Shi; Hong-Lei Ma; You-Wen Zhuang; Xiao-Xi Wang; Yi Jiang; H Eric Xu
Journal:  Acta Pharmacol Sin       Date:  2019-06-11       Impact factor: 6.150

3.  Telomere dysfunction cooperates with epigenetic alterations to impair murine embryonic stem cell fate commitment.

Authors:  Aditi Qamra; Tsz Wai Chu; Mélanie Criqui; Monika Sharma; Julissa Tsao; Danielle A Henry; Dalia Barsyte-Lovejoy; Cheryl H Arrowsmith; Neil Winegarden; Mathieu Lupien; Lea Harrington
Journal:  Elife       Date:  2020-04-16       Impact factor: 8.140

Review 4.  Epigenetic regulation of HIV-1 latency: focus on polycomb group (PcG) proteins.

Authors:  Sheraz Khan; Mazhar Iqbal; Muhammad Tariq; Shahid M Baig; Wasim Abbas
Journal:  Clin Epigenetics       Date:  2018-02-05       Impact factor: 6.551

Review 5.  Thiadiazole derivatives as anticancer agents.

Authors:  Monika Szeliga
Journal:  Pharmacol Rep       Date:  2020-09-03       Impact factor: 3.024

Review 6.  Polycomb Repressive Complex 2 in Eukaryotes-An Evolutionary Perspective.

Authors:  Mallika Vijayanathan; María Guadalupe Trejo-Arellano; Iva Mozgová
Journal:  Epigenomes       Date:  2022-01-17

Review 7.  Diversity of Dysregulated Long Non-Coding RNAs in HBV-Related Hepatocellular Carcinoma.

Authors:  Nazia Samudh; Creanne Shrilall; Patrick Arbuthnot; Kristie Bloom; Abdullah Ely
Journal:  Front Immunol       Date:  2022-01-28       Impact factor: 7.561

Review 8.  Polycomb Directed Cell Fate Decisions in Development and Cancer.

Authors:  Beatriz German; Leigh Ellis
Journal:  Epigenomes       Date:  2022-09-06

9.  MiR-34 inhibits polycomb repressive complex 2 to modulate chaperone expression and promote healthy brain aging.

Authors:  Jason R Kennerdell; Nan Liu; Nancy M Bonini
Journal:  Nat Commun       Date:  2018-10-10       Impact factor: 14.919

10.  suz12 inactivation in p53- and nf1-deficient zebrafish accelerates the onset of malignant peripheral nerve sheath tumors and expands the spectrum of tumor types.

Authors:  Felix Oppel; Dong H Ki; Mark W Zimmerman; Kenneth N Ross; Ting Tao; Hui Shi; Shuning He; Jon C Aster; A Thomas Look
Journal:  Dis Model Mech       Date:  2020-08-27       Impact factor: 5.758

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.